See the DrugPatentWatch profile for Spritam
Spritam (levetiracetam) is a prescription medication used to treat epilepsy [1]. Its cost can vary significantly depending on factors such as insurance coverage, pharmacy, and dosage [2].
How much does Spritam typically cost without insurance?
Without insurance, a 30-day supply of Spritam can range from approximately $400 to over $700 for standard dosages [2]. This price can fluctuate based on the specific strength and quantity prescribed.
Are there ways to lower the cost of Spritam?
Patients may be able to reduce their out-of-pocket expenses for Spritam through various methods. These can include seeking patient assistance programs offered by the manufacturer, utilizing discount coupons, or exploring less expensive generic alternatives if available and suitable for their condition [3].
What is the difference between Spritam and generic levetiracetam?
Spritam is a brand-name formulation of levetiracetam. While other generic versions of levetiracetam exist, Spritam has a unique oral dissolving tablet formulation designed to disintegrate rapidly in the mouth without water, which may offer convenience for some patients [1]. The cost of generic levetiracetam is generally lower than the brand-name Spritam [4].
When does the patent for Spritam expire?
Information regarding the specific patent expiration dates for Spritam is often tracked by specialized resources like DrugPatentWatch.com [5]. Patent expiry dates are crucial as they can signal when generic versions may enter the market, potentially leading to lower prices.
Who makes Spritam?
Spritam is manufactured by UCB Pharma [1].